The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy

Darko Vucicevic, Steven Jay Lester, Christopher P. Appleton, Prasad M. Panse, John William Schleifer, Susan Wilansky

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: The development of a left ventricular (LV) apical pouch in patients with apical hypertrophic cardiomyopathy (aHCM) has been thought to be the transition point that can become an apical aneurysm, which is linked to higher risk of adverse events. In our study, we sought to compare the ability of transthoracic echocardiography (echo) and cardiac magnetic resonance imaging (cMRI) to accurately identify the presence of an apical pouch or aneurysm in patients with aHCM. Methods: We retrospectively reviewed the charts of all consecutive patients that had features of aHCM on imaging. Data from cMRI and echo examinations were abstracted, and the ability of these diagnostic modalities to identify the presence of a LV apical pouch and aneurysm was analyzed. Results: Of 31 patients with aHCM, 17 (54.8%) had an apical pouch and 2 were found to have apical aneurysm (6.5%) on cMRI. Echo with and without perflutren contrast was able to accurately identify both aneurysms, but only 47.1% (8/17) of apical pouches seen by cMRI. Two patients had apical thrombus that was identified by cMRI, but not by echo. Conclusion: Our findings indicate that cMRI is superior to echo in identifying apical pouches in patients with aHCM. Our results also suggest that in patients undergoing echo, the use of perflutren contrast for LV opacification increases the diagnostic yield. Further study is necessary to delineate whether earlier identification of an apical pouch will be of clinical benefit for patients with aHCM by altering clinical management and avoiding adverse cardiovascular events.

Original languageEnglish (US)
JournalEchocardiography
DOIs
StateAccepted/In press - 2015

Fingerprint

Hypertrophic Cardiomyopathy
Magnetic Resonance Imaging
perflutren
Aneurysm
Echocardiography
Thrombosis

Keywords

  • Apical aneurysm
  • Apical hypertrophic cardiomyopathy
  • Apical pouch
  • Cardiac magnetic resonance imaging
  • Echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy. / Vucicevic, Darko; Lester, Steven Jay; Appleton, Christopher P.; Panse, Prasad M.; Schleifer, John William; Wilansky, Susan.

In: Echocardiography, 2015.

Research output: Contribution to journalArticle

@article{bc28ced3742345b182b29296852af367,
title = "The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy",
abstract = "Background: The development of a left ventricular (LV) apical pouch in patients with apical hypertrophic cardiomyopathy (aHCM) has been thought to be the transition point that can become an apical aneurysm, which is linked to higher risk of adverse events. In our study, we sought to compare the ability of transthoracic echocardiography (echo) and cardiac magnetic resonance imaging (cMRI) to accurately identify the presence of an apical pouch or aneurysm in patients with aHCM. Methods: We retrospectively reviewed the charts of all consecutive patients that had features of aHCM on imaging. Data from cMRI and echo examinations were abstracted, and the ability of these diagnostic modalities to identify the presence of a LV apical pouch and aneurysm was analyzed. Results: Of 31 patients with aHCM, 17 (54.8{\%}) had an apical pouch and 2 were found to have apical aneurysm (6.5{\%}) on cMRI. Echo with and without perflutren contrast was able to accurately identify both aneurysms, but only 47.1{\%} (8/17) of apical pouches seen by cMRI. Two patients had apical thrombus that was identified by cMRI, but not by echo. Conclusion: Our findings indicate that cMRI is superior to echo in identifying apical pouches in patients with aHCM. Our results also suggest that in patients undergoing echo, the use of perflutren contrast for LV opacification increases the diagnostic yield. Further study is necessary to delineate whether earlier identification of an apical pouch will be of clinical benefit for patients with aHCM by altering clinical management and avoiding adverse cardiovascular events.",
keywords = "Apical aneurysm, Apical hypertrophic cardiomyopathy, Apical pouch, Cardiac magnetic resonance imaging, Echocardiography",
author = "Darko Vucicevic and Lester, {Steven Jay} and Appleton, {Christopher P.} and Panse, {Prasad M.} and Schleifer, {John William} and Susan Wilansky",
year = "2015",
doi = "10.1111/echo.13118",
language = "English (US)",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy

AU - Vucicevic, Darko

AU - Lester, Steven Jay

AU - Appleton, Christopher P.

AU - Panse, Prasad M.

AU - Schleifer, John William

AU - Wilansky, Susan

PY - 2015

Y1 - 2015

N2 - Background: The development of a left ventricular (LV) apical pouch in patients with apical hypertrophic cardiomyopathy (aHCM) has been thought to be the transition point that can become an apical aneurysm, which is linked to higher risk of adverse events. In our study, we sought to compare the ability of transthoracic echocardiography (echo) and cardiac magnetic resonance imaging (cMRI) to accurately identify the presence of an apical pouch or aneurysm in patients with aHCM. Methods: We retrospectively reviewed the charts of all consecutive patients that had features of aHCM on imaging. Data from cMRI and echo examinations were abstracted, and the ability of these diagnostic modalities to identify the presence of a LV apical pouch and aneurysm was analyzed. Results: Of 31 patients with aHCM, 17 (54.8%) had an apical pouch and 2 were found to have apical aneurysm (6.5%) on cMRI. Echo with and without perflutren contrast was able to accurately identify both aneurysms, but only 47.1% (8/17) of apical pouches seen by cMRI. Two patients had apical thrombus that was identified by cMRI, but not by echo. Conclusion: Our findings indicate that cMRI is superior to echo in identifying apical pouches in patients with aHCM. Our results also suggest that in patients undergoing echo, the use of perflutren contrast for LV opacification increases the diagnostic yield. Further study is necessary to delineate whether earlier identification of an apical pouch will be of clinical benefit for patients with aHCM by altering clinical management and avoiding adverse cardiovascular events.

AB - Background: The development of a left ventricular (LV) apical pouch in patients with apical hypertrophic cardiomyopathy (aHCM) has been thought to be the transition point that can become an apical aneurysm, which is linked to higher risk of adverse events. In our study, we sought to compare the ability of transthoracic echocardiography (echo) and cardiac magnetic resonance imaging (cMRI) to accurately identify the presence of an apical pouch or aneurysm in patients with aHCM. Methods: We retrospectively reviewed the charts of all consecutive patients that had features of aHCM on imaging. Data from cMRI and echo examinations were abstracted, and the ability of these diagnostic modalities to identify the presence of a LV apical pouch and aneurysm was analyzed. Results: Of 31 patients with aHCM, 17 (54.8%) had an apical pouch and 2 were found to have apical aneurysm (6.5%) on cMRI. Echo with and without perflutren contrast was able to accurately identify both aneurysms, but only 47.1% (8/17) of apical pouches seen by cMRI. Two patients had apical thrombus that was identified by cMRI, but not by echo. Conclusion: Our findings indicate that cMRI is superior to echo in identifying apical pouches in patients with aHCM. Our results also suggest that in patients undergoing echo, the use of perflutren contrast for LV opacification increases the diagnostic yield. Further study is necessary to delineate whether earlier identification of an apical pouch will be of clinical benefit for patients with aHCM by altering clinical management and avoiding adverse cardiovascular events.

KW - Apical aneurysm

KW - Apical hypertrophic cardiomyopathy

KW - Apical pouch

KW - Cardiac magnetic resonance imaging

KW - Echocardiography

UR - http://www.scopus.com/inward/record.url?scp=84952815182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952815182&partnerID=8YFLogxK

U2 - 10.1111/echo.13118

DO - 10.1111/echo.13118

M3 - Article

C2 - 26620134

AN - SCOPUS:84952815182

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

ER -